Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)
China flag China · Delayed Price · Currency is CNY
34.40
-0.30 (-0.86%)
Nov 13, 2024, 3:00 PM CST

Tianjin Pharmaceutical Da Ren Tang Group Corporation Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
932.37986.71861.79769.14661.7625.57
Upgrade
Depreciation & Amortization
127.78127.78116.56115.53110.8598.15
Upgrade
Other Amortization
5.375.374.112.262.713.09
Upgrade
Loss (Gain) From Sale of Assets
-0.15-0.15-1.08-12.32-7.54-29.94
Upgrade
Asset Writedown & Restructuring Costs
44.3644.3620.161.930.920.78
Upgrade
Loss (Gain) From Sale of Investments
-308.11-308.11-274.22-213.49-160.41-182.73
Upgrade
Provision & Write-off of Bad Debts
19.0919.099.224.896.35-0.35
Upgrade
Other Operating Activities
579.6838.9254.0232.6817.8143.33
Upgrade
Change in Accounts Receivable
74.0174.01-732.29-42.07-113.81-102.7
Upgrade
Change in Inventory
-165.34-165.3458.87-47.4110.96-292.56
Upgrade
Change in Accounts Payable
-56.06-56.06609.67220.213.81380.44
Upgrade
Change in Other Net Operating Assets
-18.98-18.986.8210.159.75-
Upgrade
Operating Cash Flow
1,175688.49677.25852.4671.42495.49
Upgrade
Operating Cash Flow Growth
85.92%1.66%-20.55%26.95%35.51%41.51%
Upgrade
Capital Expenditures
-137.06-140.93-107.9-156.95-189.16-205.61
Upgrade
Sale of Property, Plant & Equipment
0.080.191.4928.716.7738.35
Upgrade
Cash Acquisitions
---47.61---
Upgrade
Investment in Securities
-1,298-606.35-65.08-334.9241.05-98.05
Upgrade
Other Investing Activities
175.91178.18206.82151.3215.12164.53
Upgrade
Investing Cash Flow
-1,259-568.91-12.28-311.8573.77-100.79
Upgrade
Long-Term Debt Issued
-870.86205.65--130
Upgrade
Total Debt Issued
1,207870.86205.65--130
Upgrade
Long-Term Debt Repaid
--807.34-39.87-1.42-1.1-353.14
Upgrade
Total Debt Repaid
-706.23-807.34-39.87-1.42-1.1-353.14
Upgrade
Net Debt Issued (Repaid)
500.9363.52165.78-1.42-1.1-223.14
Upgrade
Issuance of Common Stock
----8.3628.3
Upgrade
Repurchase of Common Stock
-22.67-22.67--1.35-0.7-
Upgrade
Common Dividends Paid
-989.6-877.33-387.43-232.06-232.61-173.35
Upgrade
Other Financing Activities
23.552.7-14.96-9.87-11.21-2.16
Upgrade
Financing Cash Flow
-487.78-833.77-236.62-244.7-237.26-370.36
Upgrade
Foreign Exchange Rate Adjustments
0.750.050.01---
Upgrade
Net Cash Flow
-571.02-714.15428.35295.85507.9324.34
Upgrade
Free Cash Flow
1,038547.56569.34695.45482.26289.87
Upgrade
Free Cash Flow Growth
103.18%-3.83%-18.13%44.21%66.37%66.27%
Upgrade
Free Cash Flow Margin
12.91%6.66%6.90%10.07%7.30%4.14%
Upgrade
Free Cash Flow Per Share
1.350.710.730.900.630.38
Upgrade
Cash Income Tax Paid
784.78765.94526.93496.73522.98598.75
Upgrade
Levered Free Cash Flow
-214.5365.73961.19149.46270.91364.73
Upgrade
Unlevered Free Cash Flow
-190.97388.14967.61151.29270.92367.78
Upgrade
Change in Net Working Capital
704.02122.61-535.27176.45-2.12-142.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.